Epclusa 400 mg/100 mg and 200 mg/50 mg film-coated tablets

Company:
Gilead Sciences Ltd
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
SofosbuvirVelpatasvir
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/16/1116/001

400mg/100mg milligram(s)

J05A

Film-coated tablet

EU/1/16/1116/002

200mg/50mg milligram(s)

J05A

Film-coated tablet